Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Adjunct Study to Assess Guided ADHD Therapy for Managing the Extent and Severity of Symptoms - A Prospective, Multicenter, Open Label, Single Arm, Intervention Study to Assess Efficacy and Safety of an At-home, Game-based Digital Therapy for Treating Clinical Symptoms of Adult Patients With Attention-Deficit/Hyperactivity Disorder (ADHD)

NCT05805176 is registered in ClinicalTrials.gov with Lumos Labs, Inc. as lead sponsor.

NCT NCT05805176
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05805176 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Adjunct Study to Assess Guided ADHD Therapy for Managing the Extent and Severity of Symptoms - A Prospective, Multicenter, Open Label, Single Arm, Intervention Study to Assess Efficacy and Safety of an At-home, Game-based Digital Therapy for Treating Clinical Symptoms of Adult Patients With Attention-Deficit/Hyperactivity Disorder (ADHD)
Lead sponsor
Lumos Labs, Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
April 15, 2023
Completion date
June 30, 2025
Enrollment
194 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

adhd